Finance

Beta
Lists
KRRO:NASDAQ
Korro Bio Inc
$13.20
+3.90%
(+0.49) 1D
$13.20
0.00% (0.00)
After hours
Closed: Jun 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KRRO...
Open
$12.65
High
$13.40
Low
$12.31
Mkt. cap
190.31M
Avg. vol.
224.56K
Volume
165.80K
52-wk high
$55.89
52-wk low
$5.20
EPS
-$11.67
Beta
3.01
Shares outstanding
14.42M
No. of employees
49
Open
$12.65
High
$13.40
Low
$12.31
Mkt. cap
190.31M
Avg. vol.
224.56K
Volume
165.80K
52-wk high
$55.89
52-wk low
$5.20
EPS
-$11.67
Beta
3.01
Shares outstanding
14.42M
No. of employees
49
News stories
From sources across the web
About Korro Bio Inc
CEO-
Employees49
Founded2014
Headquarters-
SectorBiotechnology
Websitekorrobio.com
Analyst ratings
Based on 8 analysts giving stock ratings to KRRO in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for KRRO in the last 3 months.
Highest
Current $13.20
$30.00 (+127.36%)
Average
$19.00 (+43.99%)
Lowest
$8.00 (-39.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
LifeSci Capital
Buy
Initiated
$21.00
+59.2%
05/30/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$30.00
+127.4%
05/28/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Maintained
$15.00
+13.7%
05/26/2026
Yigal Nochomovitz
Citi
Buy
Initiated
$21.00
+59.2%
05/18/2026
Myles Minter
William Blair
Buy
Maintained
-
-
05/18/2026
Catherine Novack
JonesTrading
Buy
Upgraded
$23.00
+74.3%
05/08/2026
Luca Issi
RBC Capital
Hold
Maintained
$8.00
-39.4%
05/08/2026
Keay Nakae
Chardan Capital
Buy
Reiterated
$15.00
+13.7%
05/07/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
$22.00
+66.7%
03/13/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Reiterated
$22.00
+66.7%
03/12/2026
William Maughan
Clear Street
Buy
Maintained
$18.00
+36.4%
03/13/2026
Ryan Deschner
Raymond James
Buy
Upgraded
$23.00
+74.3%
03/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.46M
1.09M
1.29M
-
Cost of goods sold
18.36M
11.26M
8.60M
11.53M
Cost of revenue
18.36M
11.26M
8.60M
11.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.30M
9.06M
8.58M
8.91M
Operating expense
10.30M
9.06M
8.58M
8.91M
Total operating expenses
28.66M
20.33M
17.18M
20.44M
Operating income
-27.20M
-19.24M
-15.88M
-20.44M
Other non operating income
1.43M
1.18M
990.00K
-
EBT including unusual items
-25.77M
-18.06M
-49.41M
-19.53M
EBT excluding unusual items
-25.77M
-18.06M
-14.89M
-19.53M
Income tax expense
1.00K
-
636.00K
95.00K
Effective tax rate
-
-
-1.29%
-0.49%
Other operating expenses
-
-
-
-
Net income
-25.77M
-18.06M
-50.04M
-19.62M
Net profit margin
-1,765.07%
-1,656.97%
-3,873.22%
-
Earnings per share
-2.74
-1.92
-1.65
-1.69
Interest and investment income
-
-
-
906.00K
Interest expense
-
-
-
-
Net interest expenses
-
-
-
906.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-25.98M
-18.06M
-15.23M
-20.06M
Gain or loss from assets sale
81.00K
-
-18.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create portfolio
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer